Clinical Trial Update: Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing buprenorphine versus morphine for neonatal opioid withdrawal syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Opioid Withdrawal Syndrome

Drugs mentioned

• Morphine (morphine)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Neonatal Opioid Withdrawal Syndrome | Phase 3 | Status: WITHDRAWN